Press Releases

1 September 2020

TRACER to support Akston Biosciences’ Phase 1 clinical study of AKS-452

22 July 2020

Akston Biosciences Receives $2.5M Milestone Payment

27 May 2020

Akston Biosciences Awarded NIDDK Phase IIb Grant

9 April 2020

Akston Biosciences Completes Series E Preferred Stock Financing

2 August 2019

Akston Biosciences Completes Licensing and Supply Agreement with Dechra Pharmaceuticals PLC

24 July 2019

Helmsley Charitable Trust and Akston Biosciences Corporation Extend Partnership

25 June 2019

Akston Biosciences Receives NIDDK Phase IIb Grant

26 May 2019

Akston Biosciences Begins Buildout of New GMP Biologics Manufacturing Facility

10 May 2019

Akston Biosciences Completes Convertible Note Financing

17 May 2018

Akston Biosciences Completes Series D Preferred Stock Financing